J Reconstr Microsurg 2014; 30(09): 635-640
DOI: 10.1055/s-0034-1376400
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Morphomic Analysis for Preoperative Donor Site Risk Assessment in Patients Undergoing Abdominal Perforator Flap Breast Reconstruction: A Proof of Concept Study

Benjamin Levi
1   Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
2   Morphomics Analytics Group, University of Michigan, Ann Arbor, Michigan
,
Jacob Rinkinen
1   Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
2   Morphomics Analytics Group, University of Michigan, Ann Arbor, Michigan
,
Kelley M. Kidwell
3   Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
,
Matthew Benedict
1   Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
,
Isaac C. Stein
1   Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
,
Jeffrey Lisiecki
1   Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
2   Morphomics Analytics Group, University of Michigan, Ann Arbor, Michigan
,
Binu Enchakalody
2   Morphomics Analytics Group, University of Michigan, Ann Arbor, Michigan
,
Stewart C. Wang
3   Department of Biostatistics, University of Michigan, Ann Arbor, Michigan
4   Department of Surgery, University of Michigan Health System, Ann Arbor, Michigan
,
Jeffrey H. Kozlow
1   Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
,
Adeyiza O. Momoh
1   Department of Surgery, Section of Plastic Surgery, University of Michigan Health System, Ann Arbor, Michigan
› Institutsangaben
Weitere Informationen

Publikationsverlauf

09. Januar 2014

09. März 2014

Publikationsdatum:
09. Juni 2014 (online)

Preview

Abstract

Background Morphomics are three-dimensional measurements of aspects of the human anatomy generated by computed tomographic (CT) imaging. The purpose of this study was to generate preliminary data on the efficacy of morphomics, as a potential risk stratification tool, in predicting abdominal donor site wound-healing complications in patients undergoing abdominal perforator flap breast reconstruction.

Patients and Methods In total, 58 consecutive patients undergoing deep inferior epigastric perforator (DIEP) flap breast reconstruction were evaluated. Using preoperative CT scan data, we quantified patients' body area, visceral and subcutaneous fat, fascia area, and body depth between T12 and L4. Associations between morphomic measures and complication rates were examined using t-tests and logistic regression.

Results Of the 58 patients, 11 (19%) patients developed a wound dehiscence and 47 (81%) patients healed their abdominal incision without complications. Patients with a dehiscence had a significantly higher body mass index (BMI) (34.32 vs. 29.26 kg/m2, p = 0.014) than patients without a dehiscence. Multiple morphometric measures including higher visceral fat area (p = 0.003) were significant predictors of abdominal donor site wound dehiscence. BMI (odds ratio [OR], 1.16; 95% confidence interval [CI], 1.03–1.32; p = 0.017) and visceral fat area (OR, 1.24; 95% CI, 1.08–1.42; p = 0.002) were independently significant predictors for wound dehiscence in the entire sample. Only visceral fat area retained its predictive ability in patients with a BMI > 30 kg/m2.

Conclusions Morphomic measurements correlate with the likelihood of developing postoperative donor site dehiscence after DIEP flap breast reconstruction. As a proof of concept study, this demonstrates that objective data obtained from CT scans may help in preoperatively assessing the risk for donor site wound healing complications in patients undergoing DIEP flap breast reconstruction.

Note

This article was presented at the 58th annual meeting of the Plastic Surgery Research Council, May 2013 in Santa Monica, CA. It was also presented at the American College of Surgeons Clinical Congress, October 2013 in Washington, DC.